Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination of chemotherapy and oxidative stress to enhance cancer cell apoptosis
Xinming Li, Yanan Hou, Jintao Zhao, et al.
Chemical Science (2020) Vol. 11, Iss. 12, pp. 3215-3222
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Glutathione-Depleting Nanomedicines for Synergistic Cancer Therapy
Xiaotong Cheng, Haidong Xu, Huan-Huan Ran, et al.
ACS Nano (2021) Vol. 15, Iss. 5, pp. 8039-8068
Closed Access | Times Cited: 286
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Junmin Zhang, Dongzhu Duan, Zi‐Long Song, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 342-394
Closed Access | Times Cited: 144
Thiol-Mediated Uptake
Quentin Laurent, Rémi Martinent, Bumhee Lim, et al.
JACS Au (2021) Vol. 1, Iss. 6, pp. 710-728
Open Access | Times Cited: 113
Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis
Yuqing Ren, Ruizhi Wang, Siyuan Weng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 57
Selenization of Small Molecule Drugs: A New Player on the Board
Cristina Morán-Serradilla, Daniel Plano, Carmen Sanmartín, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7759-7787
Closed Access | Times Cited: 21
The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
Paul Manoukian, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 61
Progress and perspective on hydrogen sulfide donors and their biomedical applications
Zi‐Long Song, Lanning Zhao, Tao Ma, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 5, pp. 1930-1977
Closed Access | Times Cited: 55
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 9
Photoredox Activation of Anhydrides for the Solvent‐Controlled Switchable Synthesis of gem‐Difluoro Compounds**
Rahul Giri, Ivan Mosiagin, Ivan Franzoni, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 42
Open Access | Times Cited: 29
Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?
Shiyi Zuo, Jiaxuan Song, Jingxuan Zhang, et al.
Theranostics (2021) Vol. 11, Iss. 15, pp. 7471-7487
Open Access | Times Cited: 39
Diselenide‐Based Dual‐Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy
Shu‐Cheng Wan, Meng‐Jie Ye, Qi‐Chao Yang, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 7
Closed Access | Times Cited: 26
Combination of metformin/efavirenz/fluoxetine exhibits profound anticancer activity via a cancer cell-specific ROS amplification
Beom-Goo Kang, Madhuri Shende, Gözde Inci, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 13
Integration of a Diselenide Unit Generates Fluorogenic Camptothecin Prodrugs with Improved Cytotoxicity to Cancer Cells
Jintao Zhao, Zihua Wang, Miao Zhong, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 17979-17991
Closed Access | Times Cited: 30
A long-wavelength fluorescent probe with a large Stokes shift for lysosome-targeted imaging of Cys and GSH
Yi-Hang Sun, Hai‐Hao Han, Jia-Min Huang, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 261, pp. 120055-120055
Closed Access | Times Cited: 28
Puromycin Prodrug Activation by Thioredoxin Reductase Overcomes Its Promiscuous Cytotoxicity
Bingbing Chang, Qianhe Xu, Hairui Guo, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3250-3261
Closed Access | Times Cited: 11
Probing into the plasma stability and microsomal stability of thiol-based prodrug derivatives: Using IYS-15, an HDAC inhibitor as the model thiol
Lingxuan Zhu, Zhiyuan Wang, Qingjiao Li, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 119, pp. 118064-118064
Closed Access
Redox dyshomeostasis-driven prodrug strategy for enhancing camptothecin-based chemotherapy: Selenization of SN38 as a case study
Junmin Xi, Yu Liu, Lin‐Jie Zhang, et al.
Bioorganic Chemistry (2025) Vol. 160, pp. 108468-108468
Closed Access
Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy
Rajeshwari Tiwari, Prashant S. Shinde, Sreejesh Sreedharan, et al.
Chemical Science (2020) Vol. 12, Iss. 7, pp. 2667-2673
Open Access | Times Cited: 30
Wedelolactone induces apoptosis and pyroptosis in retinoblastoma through promoting ROS generation
Hua Jiang, Chuanqiang Niu, Yiqun Guo, et al.
International Immunopharmacology (2022) Vol. 111, pp. 108855-108855
Closed Access | Times Cited: 17
Cooperatively enhanced photothermal-chemotherapyviasimultaneously downregulating HSPs and promoting DNA alkylation in cancer cells
Yang Zou, Daipeng Huang, Shan He, et al.
Chemical Science (2022) Vol. 14, Iss. 4, pp. 1010-1017
Open Access | Times Cited: 17
Design, Synthesis, and Biological Evaluation of Newly Synthesized Cinnamide-Fluorinated Containing Compounds as Bioactive Anticancer Agents
Dalal Nasser Binjawhar, Fawziah A. Al‐Salmi, Maha Al‐Ghamdi, et al.
ACS Omega (2024) Vol. 9, Iss. 16, pp. 18505-18515
Open Access | Times Cited: 3
Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation
Zhuang Li, Rong-Liang Mo, Jun-feng Gong, et al.
Phytomedicine (2024) Vol. 129, pp. 155661-155661
Open Access | Times Cited: 3
Dual-Stimuli Regulation of DNAzyme Cleavage Reaction by Coordination-Driven Nanoprobes for Cancer Cell Imaging
Yinbo Ban, Fu Zhou, Hao Wang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 24, pp. 30766-30775
Closed Access | Times Cited: 3
Loss of thioredoxin reductase function in a mouse stroke model disclosed by a two-photon fluorescent probe
Jintao Zhao, Yuan Qu, Hao Gao, et al.
Chemical Communications (2020) Vol. 56, Iss. 90, pp. 14075-14078
Closed Access | Times Cited: 26
Glutathione‐triggered prodrugs: Design strategies, potential applications, and perspectives
Jintao Zhao, Xinming Li, Tao Ma, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1013-1054
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top